DK1019507T3 - Aminoterminalt afkortede RANTES som kemokinantagonister - Google Patents

Aminoterminalt afkortede RANTES som kemokinantagonister

Info

Publication number
DK1019507T3
DK1019507T3 DK98951476T DK98951476T DK1019507T3 DK 1019507 T3 DK1019507 T3 DK 1019507T3 DK 98951476 T DK98951476 T DK 98951476T DK 98951476 T DK98951476 T DK 98951476T DK 1019507 T3 DK1019507 T3 DK 1019507T3
Authority
DK
Denmark
Prior art keywords
amino
terminally truncated
chemokine antagonists
truncated rantes
rantes
Prior art date
Application number
DK98951476T
Other languages
Danish (da)
English (en)
Inventor
Paul Proost
Sofie Struyf
Damme Jo Van
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1019507(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1019507T3 publication Critical patent/DK1019507T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98951476T 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister DK1019507T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97116863A EP0906954A1 (fr) 1997-09-29 1997-09-29 C-C chémokine tronquée à l'aminoterminus comme antagoniste de chémokines
EP97122471A EP0905240A1 (fr) 1997-09-29 1997-12-19 Amino-terminale tronquée C-C chemokin et d'un antagoniste chemokin
EP98104216A EP0905241A1 (fr) 1997-09-29 1998-03-10 Amino-terminale tronquée C-C chemokine et d'un antagoniste de chemokin

Publications (1)

Publication Number Publication Date
DK1019507T3 true DK1019507T3 (da) 2004-07-19

Family

ID=8227408

Family Applications (3)

Application Number Title Priority Date Filing Date
DK98951476T DK1019507T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister
DK04007579T DK1439231T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister
DK98947553T DK1021541T3 (da) 1997-09-29 1998-09-28 Aminoterminalt trunkeret MCP-2 som chemokinantagonister

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK04007579T DK1439231T3 (da) 1997-09-29 1998-09-28 Aminoterminalt afkortede RANTES som kemokinantagonister
DK98947553T DK1021541T3 (da) 1997-09-29 1998-09-28 Aminoterminalt trunkeret MCP-2 som chemokinantagonister

Country Status (29)

Country Link
US (5) US6905676B2 (fr)
EP (6) EP0906954A1 (fr)
JP (2) JP4230659B2 (fr)
KR (2) KR100542934B1 (fr)
CN (3) CN1233415C (fr)
AR (2) AR013528A1 (fr)
AT (3) ATE264390T1 (fr)
AU (2) AU750606B2 (fr)
BG (2) BG64679B1 (fr)
BR (2) BR9812394A (fr)
CA (2) CA2305017A1 (fr)
CY (1) CY1110927T1 (fr)
CZ (2) CZ299478B6 (fr)
DE (3) DE69822856T2 (fr)
DK (3) DK1019507T3 (fr)
EA (2) EA003942B1 (fr)
EE (2) EE200000151A (fr)
ES (3) ES2287601T3 (fr)
HK (3) HK1062637A1 (fr)
HU (2) HU226414B1 (fr)
IL (2) IL135351A (fr)
NO (2) NO20001584D0 (fr)
NZ (3) NZ516027A (fr)
PL (2) PL197569B1 (fr)
PT (3) PT1019507E (fr)
SK (2) SK286439B6 (fr)
UA (2) UA73080C2 (fr)
WO (2) WO1999016877A1 (fr)
ZA (2) ZA988675B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
WO1999028474A2 (fr) * 1997-12-01 1999-06-10 The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services Variants de chemokine et leurs procedes d'utilisation
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
CA2387378A1 (fr) * 1999-10-25 2001-05-03 Euroscreen S.A. Chimiokines humaines phc-1 et phc-2 traitees
EP1167527A1 (fr) * 2000-06-22 2002-01-02 Euroscreen S.A. Chemokines humaines tronquées: PHC-1 et PHC-2
AU2505601A (en) * 1999-11-15 2001-05-30 Wolf-Georg Forssmann Novel use of hcc-2
CA2316405A1 (fr) * 2000-05-26 2001-11-26 Ian Clark-Lewis Modulation de l'inflammation a l'aide de produits du type protease
EP1176200A3 (fr) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Utilisation des polypeptides ou leurs acides nucléiques pour le diagnose ou traitement des maladies de la peau ou de la cicatrisation de blessures et leurs utilisations pour l'identification des substances pharmacologiquement actives
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB2373785A (en) * 2001-03-28 2002-10-02 Rega Inst For Medical Res Truncating chemokines using dipeptidyl peptidase IV
IL162600A0 (en) 2001-12-17 2005-11-20 Applied Research Systems Cc-chemokine mutants as cc-chemokine antagonists
WO2004104216A2 (fr) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics et agents therapeutiques destines a des maladies liees a une dipeptidylpeptidase iv (dpp4)
DE102005049637A1 (de) * 2005-10-14 2007-04-26 Rheinisch-Westfälische Technische Hochschule Aachen Antagonisten gegen die Interaktion von PF4 und RANTES
MX2010001307A (es) 2007-08-02 2010-07-30 Novimmune Sa Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos.
WO2011097567A1 (fr) * 2010-02-08 2011-08-11 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Essai multiplexé du rantes, variants du rantes se rapportant à une maladie, et variants du rantes se rapportant à une activité enzymatique
US9296803B2 (en) 2010-03-11 2016-03-29 Health Research, Inc. Methods and compositions containing Fc fusion proteins for enhancing immune responses
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
CA3101052A1 (fr) 2018-05-28 2019-12-05 ORION Biotechnology Switzerland Sarl Methodes d'inhibition de l'inflammation cerebrale
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US11402391B2 (en) 2020-12-21 2022-08-02 Incelldx, Inc. Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311107A3 (fr) 1987-10-08 1990-04-18 Stichting REGA V.Z.W. Fluoro-3'-purine-didéoxy-2',3'-ribosides actifs contre HIV
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
MX9703889A (es) * 1994-12-08 1997-08-30 Glaxo Group Ltd Peptido rantes y fragmentos y composiciones que lo contienen, para el tratamiento de la inflamacion.
WO1997025427A1 (fr) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mpc-2)
AU733925C (en) * 1996-03-27 2002-06-13 Icos Corporation Monocyte chemotactic protein-5 materials and methods
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use

Also Published As

Publication number Publication date
IL135352A (en) 2006-08-20
NZ516027A (en) 2003-05-30
BG64757B1 (bg) 2006-02-28
PL197569B1 (pl) 2008-04-30
CN1490049A (zh) 2004-04-21
BR9812394A (pt) 2000-09-12
HU226414B1 (en) 2008-11-28
KR100542934B1 (ko) 2006-01-11
US20030119148A1 (en) 2003-06-26
DE69823218T2 (de) 2004-08-26
HK1062637A1 (en) 2004-11-19
JP4230659B2 (ja) 2009-02-25
NZ503235A (en) 2002-08-28
PT1019507E (pt) 2004-06-30
US20030124677A1 (en) 2003-07-03
CN1145693C (zh) 2004-04-14
HK1032426A1 (en) 2001-07-20
JP2001518297A (ja) 2001-10-16
HUP0003563A3 (en) 2005-11-28
CA2305017A1 (fr) 1999-04-08
ES2215324T3 (es) 2004-10-01
CZ20001147A3 (cs) 2000-09-13
EP1019507A1 (fr) 2000-07-19
KR100560275B1 (ko) 2006-03-10
UA73080C2 (en) 2005-06-15
EA200000378A1 (ru) 2000-10-30
HUP0003505A3 (en) 2005-11-28
US20050201977A1 (en) 2005-09-15
BG64679B1 (bg) 2005-11-30
WO1999016877A1 (fr) 1999-04-08
BG104266A (en) 2000-11-30
SK4512000A3 (en) 2000-09-12
ES2218860T3 (es) 2004-11-16
EP0905240A1 (fr) 1999-03-31
CN1148447C (zh) 2004-05-05
AR013528A1 (es) 2000-12-27
UA73081C2 (en) 2005-06-15
HUP0003505A2 (hu) 2001-02-28
ATE263242T1 (de) 2004-04-15
CY1110927T1 (el) 2015-06-10
KR20010024213A (ko) 2001-03-26
CZ299479B6 (cs) 2008-08-06
HK1032425A1 (en) 2001-07-20
NO20001584L (no) 2000-03-27
BG104267A (en) 2000-11-30
CZ20001146A3 (cs) 2000-09-13
US6977071B2 (en) 2005-12-20
NO20001609L (no) 2000-03-28
US7326411B2 (en) 2008-02-05
ES2287601T3 (es) 2007-12-16
WO1999016876A1 (fr) 1999-04-08
EP1021541A1 (fr) 2000-07-26
IL135351A (en) 2006-08-20
EP1439231A2 (fr) 2004-07-21
PL339545A1 (en) 2000-12-18
ZA988675B (en) 1999-11-24
JP4233214B2 (ja) 2009-03-04
DE69823218D1 (de) 2004-05-19
DE69838188T2 (de) 2007-11-22
PL339559A1 (en) 2000-12-18
JP2001518296A (ja) 2001-10-16
US7338653B2 (en) 2008-03-04
US20050220790A1 (en) 2005-10-06
EP1439231A3 (fr) 2004-12-22
US20050164936A1 (en) 2005-07-28
EE200000151A (et) 2001-02-15
DE69822856D1 (de) 2004-05-06
EE200000152A (et) 2001-02-15
SK4502000A3 (en) 2000-09-12
AU9442098A (en) 1999-04-23
DK1021541T3 (da) 2004-08-02
ATE368742T1 (de) 2007-08-15
PT1021541E (pt) 2004-07-30
BR9812565A (pt) 2000-08-01
PT1439231E (pt) 2007-08-20
SK286495B6 (sk) 2008-11-06
DE69822856T2 (de) 2004-08-19
CA2304827A1 (fr) 1999-04-08
EP0905241A1 (fr) 1999-03-31
EA003942B1 (ru) 2003-10-30
NO20001584D0 (no) 2000-03-27
EP1439231B1 (fr) 2007-08-01
NZ503234A (en) 2002-06-28
AU750341B2 (en) 2002-07-18
DK1439231T3 (da) 2007-11-05
ATE264390T1 (de) 2004-04-15
ZA988676B (en) 1999-12-03
EP0906954A1 (fr) 1999-04-07
HUP0003563A2 (hu) 2001-02-28
EA003940B1 (ru) 2003-10-30
DE69838188D1 (de) 2007-09-13
KR20010024214A (ko) 2001-03-26
PL196427B1 (pl) 2008-01-31
US6905676B2 (en) 2005-06-14
AU9747498A (en) 1999-04-23
EP1021541B1 (fr) 2004-04-14
CZ299478B6 (cs) 2008-08-06
NO20001609D0 (no) 2000-03-28
EA200000379A1 (ru) 2000-10-30
CN1233415C (zh) 2005-12-28
HU226468B1 (en) 2008-12-29
CN1271385A (zh) 2000-10-25
CN1271386A (zh) 2000-10-25
EP1019507B1 (fr) 2004-03-31
AU750606B2 (en) 2002-07-25
SK286439B6 (sk) 2008-10-07
AR013529A1 (es) 2000-12-27

Similar Documents

Publication Publication Date Title
DK1019507T3 (da) Aminoterminalt afkortede RANTES som kemokinantagonister
FI971685A (fi) Takykiniini-antagonisteja
TR199801594A3 (tr) CCR-3 reseptör antagonistleri.
ID19632A (id) Turunan-turunan 4-hidroksi-piperidina
DK0871623T3 (da) 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
DK0869955T3 (da) N-acyl-2-substituerede-4-(benzimidazolyl- eller midazopyridinyl- substituerede grupper)-piperidiner som tachykinin-antagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
MA24648A1 (fr) Electrolyseur
NO995782L (no) Kvarternaere ammoniumforbindelser som tachykinin-antagonister
ID17678A (id) Turunan-turunan 4-hidroksi-piperidina
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
ITBZ940040A0 (it) Sottotegola/sottocoppo.
IL135351A0 (en) Truncated rantes as chemokine antagonist
DK0964867T3 (da) Tachykininantagonister
IT242690Y1 (it) Tappo di sughero
UA1746S (uk) Банка
UA25677A (uk) Горілка
FI935663A0 (fi) Bindemedel som ersaetter bitumen i asfalt
FI971570A0 (fi) Styrsystem foer foerbraenningsluften i en ackumulerande, vedeldad eldstad
UA1722S (uk) Пляшка
UA1561S (uk) Пляшка
UA1560S (uk) Пляшка
UA1565S (uk) Пляшка
UA1562S (uk) Пляшка
UA1563S (uk) Пляшка